A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella

Common vaccines for infectious diseases have been repurposed as cancer immunotherapies. The intratumoral administration of these repurposed vaccines can induce immune cell infiltration into the treated tumor. Here, we have used an approved trivalent live attenuated measles, mumps, and rubella (MMR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Fusciello, Manlio, Ylösmäki, Erkko, Feola, Sara, Uoti, Arttu, Martins, Beatriz, Aalto, Karri, Hamdan, Firas, Chiaro, Jacopo, Russo, Salvatore, Viitala, Tapani, Cerullo, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065466/
https://www.ncbi.nlm.nih.gov/pubmed/35572195
http://dx.doi.org/10.1016/j.omto.2022.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065466/
https://www.ncbi.nlm.nih.gov/pubmed/35572195
http://dx.doi.org/10.1016/j.omto.2022.04.002

Ejemplares similares